Abstract
Colonization of the lungs of cystic fibrosis (CF) patients by the opportunistic bacterial pathogen Pseudomonas aeruginosa is the principal cause of mortality in CF populations1,2. Pseudomonas aeruginosa infections generally persist despite the use of long-term antibiotic therapy1,3. This has been explained by postulating that P. aeruginosa forms an antibiotic-resistant biofilm4,5 consisting of bacterial communities embedded in an exopolysaccharide matrix. Alternatively, it has been proposed that resistant P. aeruginosa variants may be selected in the CF respiratory tract by antimicrobial therapy itself1,6. Here we report that both explanations are correct, and are interrelated. We found that antibiotic-resistant phenotypic variants of P. aeruginosa with enhanced ability to form biofilms arise at high frequency both in vitro and in the lungs of CF patients. We also identified a regulatory protein (PvrR) that controls the conversion between antibiotic-resistant and antibiotic-susceptible forms. Compounds that affect PvrR function could have an important role in the treatment of CF infections.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
£199.00 per year
only £3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Govan, J. R. & Deretic, V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60, 539–574 (1996).
Smith, J. J., Travis, S. M., Greenberg, E. P. & Welsh, M. J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229–236 (1996).
Hoiby, N. Antibiotic therapy for chronic infection of pseudomonas in the lung. Annu. Rev. Med. 44, 1–10 (1993).
Singh, P. K. et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762–764 (2000).
Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999).
Speert, D. P. et al. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis. J. Clin. Microbiol. 28, 188–194 (1990).
Rahme, L. G. et al. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268, 1899–1902 (1995).
Haussler, S., Tummler, B., Weissbrodt, H., Rohde, M. & Steinmetz, I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 29, 621–625 (1999).
Drumm, B., Neumann, A. W., Policova, Z. & Sherman, P. M. Bacterial cell surface hydrophobicity properties in the mediation of in vitro adhesion by the rabbit enteric pathogen Escherichia coli strain RDEC-1. J. Clin. Invest. 84, 1588–1594 (1989).
Hentzer, M. et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183, 5395–5401 (2001).
Henderson, I. R., Owen, P. & Nataro, J. P. Molecular switches—the ON and OFF of bacterial phase variation. Mol. Microbiol. 33, 919–932 (1999).
Grewal, S. I., Han, B. & Johnstone, K. Identification and characterization of a locus which regulates multiple functions in Pseudomonas tolaasii, the cause of brown blotch disease of Agaricus bisporus. J. Bacteriol. 177, 4658–4668 (1995).
Holloway, B. W., Krishnapillai, V. & Morgan, A. F. Chromosomal genetics of Pseudomonas. Microbiol. Rev. 43, 73–102 (1979).
Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251–1254 (2000).
Han, B., Pain, A. & Johnstone, K. Spontaneous duplication of a 661 bp element within a two-component sensor regulator gene causes phenotypic switching in colonies of Pseudomonas tolaasii, cause of brown blotch disease of mushrooms. Mol. Microbiol. 25, 211–218 (1997).
Lewis, K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45, 999–1007 (2001).
Mah, T. F. & O'Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34–39 (2001).
McNamara, P. J. & Proctor, R. A. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int. J. Antimicrob. Agents 14, 117–122 (2000).
Ausubel, F. M. et al. Short Protocols in Molecular Biology (Greene Publishing and Wiley, New York, 1992).
O'Toole, G. A. & Kolter, R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28, 449–461 (1998).
Sherman, P. M., Houston, W. L. & Boedeker, E. C. Functional heterogeneity of intestinal Escherichia coli strains expressing type 1 somatic pili (fimbriae): assessment of bacterial adherence to intestinal membranes and surface hydrophobicity. Infect. Immun. 49, 797–804 (1985).
Christensen, B. B. et al. Molecular tools for study of biofilm physiology. Methods Enzymol. 310, 20–42 (1999).
Bloemberg, G. V., O'Toole, G. A., Lugtenberg, B. J. & Kolter, R. Green fluorescent protein as a marker for Pseudomonas spp. Appl. Environ. Microbiol. 63, 4543–4551 (1997).
Samadpour, M., Moseley, S. L. & Lory, S. Biotinylated DNA probes for exotoxin A and pilin genes in the differentiation of Pseudomonas aeruginosa strains. J. Clin. Microbiol. 26, 2319–2323 (1988).
Andrews, J. M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48, (Suppl. A) 5–16 (2001).
Figurski, D. H. & Helinski, D. R. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl Acad. Sci. USA 76, 1648–1652 (1979).
Schweizer, H. P. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97, 109–121 (1991).
Donnenberg, M. S. & Kaper, J. B. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59, 4310–4317 (1991).
Acknowledgements
We thank J. Lai and R. A. Rogers for image analysis of biofilm structures; T. Mylonakis for help in obtaining the samples and clinical data from CF patients; M. J. Ferraro and K. Henry for providing the CF sputum samples; and M. Wildermuth for help analysing protein sequences. This work was supported by grants from Aventis SA and the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The work described in this manuscript was supported by Aventis SA, a pharmaceutical compnay. Although the data as described has no direct commercial application, it could be perceived that Aventis SA has a financial stake in the outcome of the experiments described. The authors have filed a patent application describing the work presented in this manuscript.
Rights and permissions
About this article
Cite this article
Drenkard, E., Ausubel, F. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416, 740–743 (2002). https://doi.org/10.1038/416740a
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/416740a